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Background: The increased male prevalence of autism spectrum disorder (ASD) may be mirrored by the early
emergence of sex differences in ASD symptoms and cognitive functioning. The female protective effect hypothesis
posits that ASD recurrence and symptoms will be higher among relatives of female probands. This study examined
sex differences and sex of proband differences in ASD outcome and in the development of ASD symptoms and
cognitive functioning among the high-risk younger siblings of ASD probands and low-risk children.
Methods: Prior to 18 months of age, 1824 infants (1241 high-risk siblings, 583 low-risk) from 15 sites were
recruited. Hierarchical generalized linear model (HGLM) analyses of younger sibling and proband sex differences
in ASD recurrence among high-risk siblings were followed by HGLM analyses of sex differences and group differences
(high-risk ASD, high-risk non-ASD, and low-risk) on the Mullen Scales of Early Learning (MSEL) subscales (Expressive and
Receptive Language, Fine Motor, and Visual Reception) at 18, 24, and 36 months and Autism Diagnostic Observation
Schedule (ADOS) domain scores (social affect (SA) and restricted and repetitive behaviors (RRB)) at 24 and 36 months.
Results: Of 1241 high-risk siblings, 252 had ASD outcomes. Male recurrence was 26.7 % and female recurrence 10.3 %,
with a 3.18 odds ratio. The HR-ASD group had lower MSEL subscale scores and higher RRB and SA scores than the HR
non-ASD group, which had lower MSEL subscale scores and higher RRB scores than the LR group. Regardless of group,
males obtained lower MSEL subscale scores, and higher ADOS RRB scores, than females. There were, however, no
significant interactions between sex and group on either the MSEL or ADOS. Proband sex did not affect ASD outcome,
MSEL subscale, or ADOS domain scores.
Conclusions: A 3.2:1 male:female odds ratio emerged among a large sample of prospectively followed high-risk
siblings. Sex differences in cognitive performance and repetitive behaviors were apparent not only in high-risk
children with ASD, but also in high-risk children without ASD and in low-risk children. Sex differences in young
children with ASD do not appear to be ASD-specific but instead reflect typically occurring sex differences seen in
children without ASD. Results did not support a female protective effect hypothesis.
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Robust elevations in the prevalence of autism spectrum
disorder (ASD) among males relative to females may or
may not be mirrored by sex differences in the emergence
of ASD symptoms among boys and girls with ASD [1]. If
present, sex differences in symptom presentation and
cognitive functioning among children with ASD may be
unique to the disorder or reflect normative sex differ-
ences present among children without ASD. Here we
report on a large-scale prospective investigation of the
high-risk younger siblings of ASD probands (and low-
risk comparison children) to both address differential
ASD occurrence and to characterize potential sex differ-
ences in the early ASD phenotype. These data afford a test
of the female protective effect hypothesis, which proposes
that the younger siblings of female probands will have
higher odds of ASD recurrence and higher levels of ASD
symptoms than the siblings of male probands.
ASD is more common in males than females [2], with
an approximate 4:1 risk ratio estimate emerging both from
literature review [3] and a school-based prevalence study
of 8-year-olds [4]. However, recent community-based as-
certainment initiatives have yielded ratios lower than 3:1
among Asian [5, 6] and European [7] children, and a non-
significant male:female difference in a Swedish population
cohort [8]. Prospective studies of high-risk infant siblings
offer a view of the emergence of the ASD phenotype
which may reduce the male ascertainment bias which has
been documented in clinic-referred samples [9]. In high-
risk sibling studies, enrollment typically occurs during
infancy prior to the onset of symptoms, and outcome is
ascertained at a fixed point, most often 3 years of age.
Variable male:female ratios in prospectively followed high-
risk sibling samples (2.8:1 [10] and 1.65:1 [11]) suggest the
importance of large-scale characterization of the risk of
ASD among high-risk siblings.
Sex differences may be present not only in ASD occur-
rence but in ASD symptoms and levels of cognitive
functioning. Females with ASD have historically pre-
sented with lower IQ than boys [3, 12, 13]. Likewise,
females diagnosed with ASD in the Simons Simplex
Collection exhibited higher levels of social affect and
communication symptoms on the Autism Diagnostic
Observation Schedule (ADOS) than males with ASD, as
well as lower verbal and nonverbal IQ [14]. However, a
recent investigation did not reveal sex differences in cog-
nitive performance or ASD symptom severity either
among 3-year-olds with ASD or among typically devel-
oping children [15]. There is, in fact, evidence of greater
ASD symptom severity—particularly elevated levels of
repetitive and restricted behavior—among males. In both
the Autism Genome Project [16] and a recent study of
3- and 4-year-olds [17], males with ASD had higher
levels of repetitive behavior than females.Recent studies on sex differences in the presentation
of children with and without ASD also suggest greater
symptom severity for males. A prospective investigation,
for example, yielded some evidence of a female advan-
tage (higher fine motor scores on the MSEL and lower
ADOS severity scores) for high-risk siblings with an
ASD outcome, high-risk siblings without an ASD out-
come, and low-risk children [11]. There was no evidence
that this sex difference varied by ASD outcome or risk
status. Although not a common focus of developmental
research, a substantial body of work on adults examines
the possibility that ASD sex differences are a reflection
of normative sex differences [18, 19]. These findings
raise the possibility that sex differences seen in the ASD
phenotype are not unique to ASD but reflect broader
sex differences in the general population.
Sex differences in ASD occurrence may suggest a
female protective effect. Clinically identified girls with
ASD carry a higher load of deleterious genetic variants
than boys [20] and may have a higher threshold for the
impact of the multifactorial array of genetic and environ-
mental factors thought to be responsible for ASD [21].
The female protective effect account hypothesizes that
first-degree relatives of female probands will exhibit
higher levels of ASD symptoms and higher levels of
ASD recurrence than the first-degree relatives of male
probands [21, 22]. Two reports indicate that the siblings
of female probands present with higher levels of parent-
reported ASD symptoms than the siblings of male pro-
bands [16, 22]. There is little evidence, however, that
siblings of female probands exhibit a differential risk for
the occurrence of categorical ASD [8, 21, 23–25].
Prospective studies of high-risk infant siblings offer a
unique perspective on the role of younger sibling sex
and proband sex in ASD occurrence and the emergence
of the ASD phenotype. A previous report from the Baby
Siblings Research Consortium (BSRC) utilizing slightly
more than half (664) of the current sample of 1241 high-
risk infants yielded an 18.7 % risk of ASD recurrence,
which was elevated among males and among siblings from
multiplex families [10]. In a subsequent BSRC report on
non-diagnosed high-risk siblings [26], males in both high-
risk (n = 507) and low-risk groups (n = 324) exhibited
higher ASD symptom severity scores—and lower levels of
verbal and nonverbal functioning—than females. No finer
distinctions were made, however, in either ASD symptoms
or cognitive functioning.
Here we report on younger sibling sex differences and
proband sex differences on the odds of ASD in a large
sample of prospectively followed high-risk siblings. Sex
differences in ASD odds provide a context for examining
younger sibling and proband sex differences in ASD-
related social affect and repetitive behavior symptom
severity, as well as multiple elements of cognitive
Table 1 Sample characteristics
High-risk High-risk Low-risk
Variable ASD
(n = 252)
Non-ASD
(n = 989)
Non-ASD
(n = 583)
Sex (% male) 76.6 52.7 50.8
Age first seen (months) 7.62 (3.58) 7.39 (3.46) 6.85 (2.94)
Age at outcome (months) 37.13 (2.06) 36.97 (1.97) 36.97 (2.18)
Proband sex (% male) 80.7 83.8 –
Multiplex (%) 15.3 5.6 –
Non-Caucasian (%) 17.6 15.3 14.2
Maternal education (% H.S.) 11.9 7.1 4.0
Paternal education (% H.S.) 16.3 11.1 9.3
H.S. high school: schooling terminated at or before high school completion
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and proband sex differences in the longitudinal develop-
ment of symptom presentation and cognitive functioning
among three groups of children: high-risk siblings with
ASD, high-risk siblings without ASD, and low-risk chil-
dren. We tested for sex and group differences in cognitive
functioning and ASD symptom severity over age. We were
particularly interested in ascertaining whether sex differ-
ences in symptom severity and cognitive functioning dif-
fered in these groups, which would be instantiated by a
statistical interaction. The absence of such an interaction
would suggest that male/female differences in symptom
severity and cognitive functioning were not unique to
ASD outcome or risk status, but instead reflected norma-
tive sex differences.Methods
Participants
Data were pooled from 15 independently funded research
sites that are part of the BSRC, an international network
supported by Autism Speaks. The BSRC database is ap-
proved by the University of California Davis Institutional
Review Board. Please see the “Acknowledgements” section
for a list of all the review boards that approved the study.
All sites used similar recruitment and sampling method-
ologies as well as standardized longitudinal diagnostic as-
sessment procedures. Families were recruited from clinics
and agencies serving individuals with ASD, community
events, website and media announcements, fliers, mailings,
and word-of-mouth. Across all sites, inclusion criteria for
the high-risk infants involved diagnostic confirmation of
ASD in probands, with no genetic or neurological condi-
tions (e.g., fragile X, tuberous sclerosis) accounting for the
ASD diagnosis. At each site, consent was provided by the
parents or legal guardians of the infant participants and
human subject’s approval was provided by the local univer-
sity institutional review board.
All participants were identified as being either the full
biological younger sibling of a proband with an ASD
diagnosis (the high-risk group) or having no first-degree
relatives with an ASD diagnosis (the low-risk group).
Inclusion required enrollment prior to 18 months and
ASD outcome categorization, which required both clin-
ical diagnosis and meeting ADOS cut-off criteria for
ASD. Inclusion in the profile analyses required ADOS
and/or MSEL data at 18 and/or 24 months of age. Final
ADOS and MSEL assessments were included in profile
analyses if they occurred from 33–38 months. Within
the LR group, there were six children (three males) with
an ASD outcome; they were removed from analyses. The
analysis data set contained 1824 infant participants, of
whom 1241 were high-risk (HR) and 583 were low-risk
(LR). Table 1 characterizes these three groups.Measures
Clinical best estimate diagnosis
Clinical best estimate (CBE) diagnoses were made or veri-
fied by licensed clinicians when infants were between 33
and 49 months of age and were informed by ADOS scores,
DSM-IV criteria, and cognitive and behavioral assessments.
Clinical diagnoses were dichotomized into either ASD (in-
cluding pervasive developmental disorder—not otherwise
specified and autistic disorder) or non-ASD.Autism Diagnostic Observation Schedule
The ADOS [27] is a standardized assessment of autism
symptoms consisting of 25 to 30 items across four symp-
tom domains: social interaction, communication, repeti-
tive and stereotyped behaviors, and play. Items are
scored as 0 (developmentally appropriate and not autis-
tic), 1 (mildly atypical), 2 (atypical and autistic in qual-
ity), or 3 (severely autistic). The ADOS yields a total
score and clinical cut-off scores for use in the diagnosis
of ASD. The ADOS also provides severity scores in each
of two symptom domains: 1) social affect (SA) involving
communication and social interaction items, and 2)
restricted and repetitive behavior (RRB) involving repeti-
tive and stereotyped behavior items. These 10-point se-
verity scores allow for examining change in symptom
severity over time as they are calibrated across different
ages and test versions [28]. Both the SA and RRB do-
main severity scores were used to investigate change in
symptoms between 24 months and 36 months.Mullen Scales of Early Learning
The Mullen Scales of Early Learning (MSEL) [29] is
designed to assess four areas of functioning: fine motor,
visual reception, expressive language, and receptive lan-
guage. Age-equivalent scores on these four subscales
were used to investigate developmental growth trajector-
ies between 18, 24, and 36 months. Age-equivalent
scores are calibrated in months and are more sensitive
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standard scores [17, 30].Analysis plan
A first set of analyses examined recurrence rates of ASD
outcome for males and female high-risk siblings. We
employed a hierarchical generalized linear model (HGLM)
wherein ASD outcome was treated as a dichotomous
dependent variable. Predictor variables included high-risk
sibling sex, proband sex, demographic variables such as
maternal education, and multiplex status. To control for
site differences in recurrence rates, site was included as a
random effect.
We next tested for sex differences and sex by group in-
teractions in cognitive functioning and ASD symptom
severity. This second set of analyses modeled sex and
group differences in the longitudinal trajectories of MSEL
subscale scores and ASD severity scores. In these models,
a group variable contrasted high-risk siblings with an ASD
outcome, high-risk siblings without an ASD outcome, and
low-risk children. These models involved profile analysis
within the framework of HGLM where subscale/domain
was treated as a repeated factor within each time point.
This allowed for the simultaneous assessment and com-
parison of growth trajectories in each subscale/domain
between by sex and group. Full factorial models were ex-
amined, which included all higher-order interactions
between sex, group, subscale/domain, and age. Of critical
importance to the current study, these models tested all
two-way and higher-order interactions between sex and
group.
The profile analysis for the MSEL included data from
three ages—18, 24, and 36 months—which permitted
modeling both random intercepts and slopes for each
subject across subscales. The profile analysis model for
the ADOS involved two ages—24 and 36 months—and
thus age was considered a repeated factor. Additionally,
for the ADOS, a negative binomial distribution with a
log link was employed to approximate domain score dis-
tributions for analyses.
All analyses were conducted in R [31] using the lme4
package [32]. All significance testing of model terms and
parameters was conducted using denominator degrees of
freedom calculated using a Satterthwaite approximation.Results
Sex differences and recurrence rates of ASD
Analyses of recurrence rates in the high-risk (HR) sample
consider the overall recurrence rate and the effects of pro-
band sex, younger sibling sex, and multiplex status. The
initial HGLM included only a random site effect, with no
fixed effect predictors. Results revealed an overall recur-
rence rate of 19.5 % (95 % CI = 15.2 to 24.6).We next examined proband sex and other demo-
graphic variables to determine whether they were associ-
ated with recurrence rates. Table 1 shows the sample
characteristics for each of these variables. Neither pro-
band sex (X2 = 0.59, df = 1, p = .44), non-Caucasian status
(X2 = 0.36, df = 1, p = .55), or paternal education (X2 =
2.09, df = 1, p = .15) was significantly associated with
ASD recurrence. There was a non-significant trend for
maternal education to be associated with recurrence rate
(X2 = 3.10, df = 1, p = .08). These characteristics did not
have significant moderating effects on infant sex or
multiplex status in predicting outcome.
To test for younger sibling sex effects, sex was entered
as a predictor of dichotomous ASD outcome over and
above the random effect for site. The overall effect for
sex was significant (X2 = 55.35, df = 1, p < .001). The
overall percentage of recurrence was 26.7 % for males
and 10.3 % for females. The odds ratio of male to female
recurrence was 3.18 (95 % CI = 2.31 to 4.39).
The impact of multiplex status was evaluated among
the 991 HR infant siblings with data on multiplex status,
of whom 77 (7.8 %) were from multiplex families. Add-
ing multiplex status to the model including sex and site
revealed a significant main effect for multiplex status
(X2 = 20.68, df = 1, p < .01), but no interaction between
sex and multiplex status (X2 = 0.04, df = 1, p = .85). The
odds ratio of recurrence in multiplex to simplex families
was 3.38 (95 % CI = 2.02 to 5.66). Thus male sex and
multiplex status were each independently associated
with an approximate 3:1 increase in the odds of ASD re-
currence. Figure 1 shows proportions of ASD recurrence
in males and females for simplex and multiplex families.
Finally, we examined the interaction between sex of the
identified proband and multiplex status among the 403
simplex and 58 multiplex families for whom data were
available (see Additional file 1). Despite elevated rates of
recurrence for infant siblings from multiplex families in
which the identified proband was female, the interaction
term was not significant (X2 = 2.71, df = 1, p = .10). Given
the small sample of female probands in multiplex families
(n = 7), these analyses should be interpreted with caution,
Profile analyses
Missing data
For both the ADOS and MSEL, missing data were
present at all ages for both sexes in all three groups.
Levels of missing data tended to be comparable for
males and females and to be more common among LR
and HR non-ASD than among the ASD group. On the
ADOS, for example, 13.9 % of data were missing at
24 months and 14.2 % were missing at 36 months. At
36 months, 14.1 % of male and 14.3 % of female ADOS
were missing; likewise, 2.4 % of HR-ASD, 17.2 % of HR-
No-ASD, and 14.2 % of LR ASD were missing. These
Table 2 MSEL profile analysis effects
Fig. 1 Proportion of ASD outcome by high-risk sibling sex and family multiplex status (±1 SE). ASD autism spectrum disorder
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of ASD indicators within the HR group are associated
with less missing data. As such, estimates of profile
scores may be biased slightly toward poorer functioning
in the LR non-ASD and HR non-ASD groups, thereby
making group comparisons slightly more conservative.Effect df F value p value
Main effects
Subscale 3, 13,141.97 283.41 <.001
Sex 1, 1734.49 77.02 <.001
Group 2, 1751.67 313.07 <.001
Age 1, 1631.21 24,379.20 <.001
Two-way interaction effects
Subscale × sex 3, 13,158.11 6.57 <.001
Subscale × group 6, 13,179.68 40.49 <.001
Sex × group 2, 1731.83 1.79 .17
Subscale × age 3, 13,144.51 261.42 <.001
Sex × age 1, 1594.41 19.52 <.001
Group × age 2, 1595.04 106.09 <.001
Three-way interaction effects
Subscale × sex × group 6, 13,135.12 0.48 .82
Subscale × sex × age 3, 13,172.63 7.72 <.001
Subscale × group × age 6, 13,196.43 5.53 <.001
Sex × group × age 2, 1614.78 0.48 .62
Four-way interaction effect
Subscale × sex × group × age 6, 13,197.46 0.26 .96MSEL developmental profiles
Results of the full factorial model of MSEL age-equivalent
scores are presented in Table 2. Figure 2 plots estimated
marginal means from this model (see Additional file 2). In
brief, all main and interaction effects of group, age, and
MSEL subscale were significant (p < .001). There was a
main effect of sex (p < .001). However, the sex by group
interaction was not significant (p = .17), and there were no
significant higher-order interactions involving sex and
group (all p > .62).
The MSEL model contained two significant three-way in-
teractions, each involving a subscale and age. A subscale by
sex by age interaction indicated developmental changes in
male and female subscale profiles. Simple effects decom-
posing this three-way interaction are presented in Add-
itional file 3. Slope comparisons between sexes revealed
that age equivalent scores increased more rapidly in females
than in males for each of the four subscales (all p < .05).
When age was re-centered at each age to test sex differ-
ences within subscales, males were significantly lower than
females at each age (all p < .001) on all but one subscale
(fine motor at 18 months). The female advantage forsignificant comparisons at each age ranged from 1.06 to
3.3 months on age-equivalent scores; effect sizes ranged
from medium to large (d range .33 to .54). Examination of
simple effects revealed that both males and females showed
Fig. 2 MSEL subscale age-equivalent scores by sex and group (±1 SE). MSEL Mullen Scales of Early Learning
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reception scores rising significantly more rapidly than other
subscales, fine motor rising significantly more slowly than
other subscales, and both language subscales rising at inter-
mediate rates.
Examination of the simple effects for the three-way
interaction (presented in Additional file 4) between out-
come group, subscale, and age revealed, as expected, that
the HR ASD group had slower growth in all four subscales
than each of the other two groups (all p < .001). The two
non-ASD groups did not differ in their visual reception
and receptive language trajectories, but the HR non-ASD
group had significantly slower growth in fine motor and
expressive language when compared to the LR non-ASD
group. Comparing group differences within subscales at
each age, the HR ASD group scored significantly below
the HR non-ASD group on all subscales at all ages (all
p < .001), and the HR non-ASD group scored below the
LR non-ASD group on all but one subscale (fine motor
at 18 months) at all ages (all p < .001).
For slope comparisons between subscales within each
outcome group, all three groups showed similar patterns of
trajectories across the subscales, with the greatest increases
in visual reception, the slowest increases in fine motor, and
both language subscales showing intermediate growth over
time. The HR ASD group, however, did appear to showless differentiation between the trajectories of the language
subscales than the two comparison groups.ADOS developmental profiles
Results of the full factorial model for the ADOS do-
main severity scores are presented in Table 3. Figure 3
displays estimated marginal means (see Additional file
5) for the full factorial model for sex and group in each
domain. In brief, the sex by group interaction was not
significant (p = .27), and there were no significant
higher-order interactions involving sex and group (all
p > .12). As in the MSEL analyses, effects of sex and
group were not associated.
There was a significant ADOS domain by sex inter-
action effect (see Additional file 6 for simple effect com-
parisons). The comparison of sex within domain revealed
that males had significantly higher RRB scores than fe-
males, a medium effect size (d = .29). SA scores did not
differ by sex. Across domains, RRB scores were higher
than SA scores for both males and females; this difference
was greater for males than for females.
Simple effect comparisons for the significant three-way
interaction between group, domain, and age are shown in
Additional file 7. The HR ASD group was significantly
higher than each of the non-ASD comparison groups at
Table 3 ADOS profile analysis effects
Effect df Wald Chi-square p value
Main effects
Domain 1 58.72 <.001
Sex 1 1.09 .30
Group 2 373.67 <.001
Age 1 0.68 .41
Two-way interaction effects
Domain × sex 1 4.90 <.05
Domain × group 2 54.74 <.001
Sex × group 2 2.65 .27
Domain × age 1 9.77 <.01
Sex × age 1 0.02 .90
Group × age 2 9.04 <.05
Three-way interaction effects
Domain × sex × group 2 0.81 .67
Domain × sex × age 1 3.22 .07
Domain × group × age 2 9.47 <.01
Sex × group × age 2 0.29 .86
Four-way interaction effect
Domain × sex × group × age 2 4.33 .12
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points (all p < .001). At 24 months, the HR non-ASD
group was significantly higher than the LR non-ASD
group in both the RRB and SA domains but, at 36 months,
was only higher in the RRB domain. SA severity scores in-
creased significantly for both the ASD and LR non-ASD
groups between 24 and 36 months, but not for the HRFig. 3 ADOS domain scores for sex and group over age (±1 SE). SA social anon-ASD group. No change in RRB over time was ob-
served for any group.
Multiplex status and proband sex as predictors in profile
analyses
Building upon the profile analysis models, we investigated
whether sex of the identified proband and multiplex status
influenced MSEL age equivalent scores and ADOS do-
main scores. For the MSEL subscales, proband sex did not
have a significant main effect (X2 = 1.42, df = 1, p = .23),
nor did it interact with group (X2 = 0.69, df = 1, p = .41) or
with infant sibling sex (X2 = 0.13, df = 1, p = .72). There
was a main effect for multiplex status (X2 = 5.33, df = 1,
p < .05), with infants from multiplex families scoring,
on average, 0.84 points (SE = 0.37) lower on MSEL
subscales than infants from simplex families. However,
multiplex status did not interact with group (X2 = 0.02,
df = 1, p = .88) or with infant sibling sex (X2 = 1.35, df =
1, p = .25).
For the ADOS profile analyses, there was no significant
main effect of proband sex (X2 = 0.09, df = 1, p = .76),
and no interaction with infant sibling sex (X2 = 0.95,
df =1, p = .33) or group (X2 = 0.19, df = 1, p = .66). Simi-
larly, for multiplex status, there was no main effect
(X2 = 0.66, df = 1, p = .42), and no interaction with in-
fant sibling sex (X2 = 0.18, df = 1, p = .67) or with group
(X2 = 0.97, df = 1, p = .33).
Discussion
This investigation of 1241 high-risk siblings offers a
prospective view of sex differences in ASD risk and the
emergence of the ASD phenotype. The odds ratio of
ASD recurrence was 3:18 for male versus female high-
risk siblings and was not impacted by proband sex.ffect, RRB restricted and repetitive behavior
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with ASD performed more poorly on cognitive sub-
scales and exhibited higher levels of ASD-symptom se-
verity than other children. Among high-risk siblings
(with and without ASD) and low-risk comparison chil-
dren, a female rather than a male advantage was evi-
dent. Across risk and outcome groups, girls performed
better than boys in all dimensions of cognitive func-
tioning assessed and exhibited a lower level of repeti-
tive behavioral severity than boys. As sex differences
were neither attenuated nor exaggerated among chil-
dren with ASD, the results highlight the role of norma-
tive sex differences in the development of the autism
phenotype. Proband sex was not associated with ASD
symptom severity or cognitive functioning, a pattern
which does not implicate a female protective effect.Sex differences in recurrence
Differences in the prevalence of ASD among males and
females are among the most well-documented features
of the disorder, but these sex differences vary by sample
and ascertainment procedure [3, 8, 33]. Methodological
strengths of the current study included prospective
tracking of a large sample of 1241 high-risk siblings,
527 of whom were female, recruited by 18 months of
age. This is the largest prospectively ascertained sample
of infants at elevated risk for ASD due to familial fac-
tors to date. Assessment of ASD outcome occurred at a
fixed time point, 3 years of age, using both clinical best
estimate diagnosis and ADOS criteria. The male rate of
ASD recurrence in the high-risk siblings was approxi-
mately 1 in 4 (26.7 %) while the female rate was 1 in 10
(10.3 %). The 3.18:1 increased odds of ASD in males in
the current sample (95 % CI = 2.31 to 4.39) is similar to
estimates from community-based ascertainment of
children (2.5:1–2.6:1) [5–7], as well as to a previous
report on approximately half of the current high-risk
sample [10].
The overall—combined male and female—ASD recur-
rence rate of 19.5 % yielded an ASD outcome for ap-
proximately one in five high-risk siblings. Multiplex
status, which characterized 8 % of the current 1241
high-risk siblings, was associated with a threefold in-
crease in ASD risk, underscoring familial risk related to
the influence of rare and common genetic variants [34,
35]. The risks associated with a high-risk sibling being
male and being from a multiplex status family were in-
dependent but cumulative. The dual impact of being a
male and being from a multiplex family resulted in an ap-
proximately one in two risks of ASD. Although consonant
with earlier reports from the sample [10], the number of
multiplex cases (n = 77) was limited, suggesting that multi-
plex results should be interpreted with caution.Proband sex
Proband sex was not associated with recurrence in the full
sample. Although the number of multiplex families with
female probands was small, proband sex also did not inter-
act with multiplex status to predict recurrence. The
current lack of evidence for a proband sex effect on recur-
rence mirrors a recent population-based study [8] and re-
ports on clinically diagnosed ASD cases [23, 24]. Although
a recent report on twins reported higher recurrence for
siblings of female probands, probands (and affected sib-
lings) were identified by thresholding (e.g., greater than
90th percentile) parent-reported autistic traits rather than
by diagnosis [22]. Likewise, previous reports that the sib-
lings of female probands present with higher levels of
ASD symptoms are based on parent-report [16, 22], while
the examiner-administered ADOS in the current investi-
gation did not yield differences in repetitive behaviors or
social affect based on sex of proband.
Sex differences and the early ASD phenotype
In contrast to sex differences in ASD occurrence, relatively
little is known about the development of sex differences in
the ASD phenotype as it emerges in early childhood. In
the current study, sex differences were assayed longitudin-
ally to investigate developmental changes in cognitive
functioning and autism symptoms among 1241 high-risk
siblings and an additional 583 low-risk children. Challen-
ging accounts of greater female affectedness, there was no
evidence that girls exhibited lower levels of cognitive func-
tioning or higher levels of symptom severity than boys.
Boys across all groups exhibited slower growth trajectories
and lower levels of cognitive performance than girls in fine
motor, visual reception, receptive and expressive language
functioning. Likewise, children with ASD outcomes, re-
gardless of sex, exhibited slower growth trajectories and
lower levels of performance than both high-risk and low-
risk children without ASD. However, sex differences and
ASD effects were not associated. There was no evidence
that boys in the HR ASD group performed disproportion-
ately more poorly than boys in the other two groups.
These findings are consistent with reports from large N
studies of a female advantage in both verbal and nonverbal
functioning among low-risk children between 1 and 3
years of age [36–39].
With respect to the ASD symptom severity indices,
males exhibited higher levels of repetitive behaviors than
females, but there were no sex differences in social affect
severity scores. Elevation in restricted and repetitive
behaviors in boys is a robust sex difference, evident in
both younger [17] and older children with ASD [16].
Children with ASD exhibited elevated levels of both re-
petitive behaviors and disturbances of social affect with
respect to HR siblings without ASD and low-risk chil-
dren. At 36 months, the high-risk group without ASD
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tive behaviors, but not social affect difficulties, than the
low-risk group. Specification of this particular area of
challenges for non-diagnosed high-risk siblings was not
possible in reports of smaller subsets of this sample [26].
Although a meta-analysis of clinical samples suggested
that elevated levels of repetitive and stereotyped behav-
iors in males emerged only after age 6 [40], the current
dataset affords a more fine-grained developmental per-
spective. While social affect severity scores increased for
the HR ASD group, these children exhibited stable and
elevated levels of restricted and repetitive behaviors be-
tween 2 and 3 years. As elevations in restricted and
repetitive behaviors were evident at age 2, these behav-
iors may be helpful in forecasting ASD outcome in both
males and females. This pattern of results points to the
potential clinical importance of prospective developmen-
tal designs in understanding sex differences in the emer-
gence of autism.
No sex differences in social affect symptoms were evi-
dent across risk and outcome groups. In low-risk chil-
dren, a small female advantage in social affect, e.g.,
more expression of positive emotions with unfamiliar
adults, can be detected [41]. Although the ADOS can
function as an index of severity, it may have limited
sensitivity to detect such subtle effects. Elevations in re-
stricted and repetitive behavior were characteristic of
all children with ASD and of boys relative to girls re-
gardless of ASD or risk status. The elevation in re-
stricted and repetitive behavior in male children and
male adults with and without ASD is consistent with a
male focus on regularity in the behavior of non-social
objects and events [19, 42, 43]. The results suggest that
male:female ASD differences are not ASD-specific but
instead reflect more general sex differences reflected
through a prism of autism-linked symptoms [11].
Limitations
The instruments used to assess sex differences among
multiple sites of Baby Sibling Research Consortium
were relatively coarse-grained behavioral assays. Neuro-
imaging and electrophysiological investigations of sex
differences in the developing brain, as well as subtler
behavioral measures of attention, joint attention, learn-
ing, and social interaction may reveal ASD-specific sex
differences not documented here. Nevertheless, an ad-
vantage in early cognitive functioning and lower levels
of restricted and repetitive behaviors were both evident
in females. Although there was no overall evidence of a
female protective effect, larger samples will be required
to address the possibility that female probands in multi-
plex families (two or more female siblings) confer
greater risk for ASD in successive offspring. Recent
findings highlight within family diversity in the de novoand rare inherited genetic mutations linked to sibling
ASD [44]. One path to greater understanding of sex dif-
ferences in ASD occurrence and symptomatology will
require genetically informed prospective designs which
document the potential impact of rare genetic variants
on a landscape of continuously distributed enabling and
protective factors [21, 34].
Conclusions
This large prospectively ascertained sample of infants
at high risk for ASD due to familial factors revealed a
three-to-one male:female odds ratio in ASD recurrence.
Children with ASD had lower levels of cognitive func-
tioning and higher symptom severity levels than high-
risk children without ASD who, in turn, exhibited lower
cognitive functioning and higher ASD symptom sever-
ity than low-risk comparison children. Regardless of
group membership, males exhibited lower levels of cog-
nitive functioning than females and higher levels of
restricted and repetitive behaviors. That is, sex differ-
ences were characteristic of the entire longitudinal
sample including both high-risk siblings (with and
without ASD) and low-risk comparison children. The
results suggest that the emergence of ASD symptoms
in high-risk siblings—both with and without eventual
ASD outcomes—occurs in the context of naturally oc-
curring sex-related variability. There was no evidence,
however, that the younger siblings of female probands
exhibited greater ASD recurrence or symptoms, casting
doubt on a female protective effect among high-risk
ASD siblings. For these children, male younger sibling
sex remains a robust risk factor for categorical and
quantitative impairment.
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